GRPA rcd4 Progressive Retinal Atrophy Testing in Irish & Gordon Setters

Progressive retinal atrophy (PRA) is a common hereditary eye disease leading to gradual vision loss and blindness in dogs. Among the variants, GRPA rcd4 specifically affects the Irish Setter and Gordon Setter breeds. This late-onset, inherited disease causes degeneration of critical photoreceptor cells in the retina, severely impacting dogs’ quality of life.

What is GRPA rcd4 Progressive Retinal Atrophy?

GRPA rcd4 stands for "generalised progressive retinal atrophy, rod-cone degeneration four." It is caused by mutations in the C2orf71 gene, leading to destruction of the rods and cones in both eyes’ retinas. These cells interpret light and colour, and their loss results in irreversible blindness. The progression is painless but devastating for the affected dog.

Which Dogs Are Affected?

This condition primarily impacts Irish Setters and Gordon Setters, with potential risks in crossbreeds containing their ancestry. Unlike other forms of PRA, GRPA rcd4 often presents later, usually after the age of 10 but sometimes between 5 and 12 years. This late onset means dogs may be used for breeding before symptoms appear, making genetic testing vital.

Understanding Heredity and Inheritance

GRPA rcd4 is inherited in an autosomal recessive way. A dog must inherit two copies of the mutated gene to develop the condition—one from each parent. Dogs with only one copy are healthy carriers; they do not show symptoms but can pass the mutation on to their offspring.

When two carrier dogs are bred, there is a 25% chance their puppies will be affected, 50% chance they will be carriers, and 25% chance they will be clear of the mutation. Responsible breeding practices should seek to avoid mating two carriers, reducing disease spread while maintaining genetic diversity.

Testing for GRPA rcd4

Genetic testing is crucial for Irish Setter and Gordon Setter breeders. Because symptoms usually appear late, DNA testing is the only way to identify carriers and affected dogs early. Testing is done by collecting a cheek swab sample, usually by a vet, and sending it to an approved laboratory. Results indicate if a dog is clear, a carrier, or affected, guiding responsible breeding decisions.

For information on laboratories approved by The Kennel Club for testing, see The Kennel Club's list of approved DNA testing labs.

Why Testing Matters for Breeders and Owners

Testing helps breeders avoid breeding two carriers together, which prevents producing affected puppies and ultimately reduces the prevalence of GRPA rcd4. It also supports the welfare of the breed by enabling healthier breeding lines while preserving genetic diversity.

For dog owners, knowing your dog’s status provides valuable information for healthcare planning and helps raise awareness of this condition in the breed community.

Summary and Responsible Ownership Advice

• GRPA rcd4 is a late-onset genetic eye disease causing blindness in Irish and Gordon Setters.
• It is inherited in an autosomal recessive pattern, where two copies of the mutated gene cause disease.
• Genetic testing is essential to identify carriers and affected dogs before breeding decisions.
• Breeders should avoid mating two carriers to reduce the incidence of this condition.
• Testing supports responsible breeding and helps protect the breed’s health long term.

Careful genetic testing and informed breeding decisions can protect your setters’ eyesight and wellbeing. If you are looking to add an Irish or Gordon Setter to your family, consider finding an Irish Setter puppy or looking for a Gordon Setter puppy from reputable breeders who test for genetic conditions such as GRPA rcd4.